South Korea has started distributing stocks of remdesivir, a drug being used to treat Covid-19.
The supply has been donated by Gilead Sciences and discussions are under way to purchase supplies in August, the Korea Centers for Disease Control said.
“Patients who are eligible for remdesivir are limited to severe patients with pneumonia and in need of oxygen therapy,” the disease control agency said in a statement.
Remdesivir is an anti-viral medicine that has been used against Ebola. The drug cut the duration of symptoms from 15 days down to 11 in a clinical trial at hospitals around the world.
It is unclear how many doses have been donated to South Korea by the US company.
BBC